← All trials
NCT06243393
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 19, 2024
- Primary completion
- Aug 1, 2028
- Completion date
- Feb 1, 2029
- First posted
- Feb 6, 2024
- Last posted
- Jul 10, 2024
- Enrollment
- 80
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of HeidelbergLead sponsor
- University of HeidelbergSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.